BROMOCRIPTINE MESYLATE

Product NDC: 63304-962
Requested package NDC: 63304-962-30
11-digit product format: 633040962
Labeler code: 63304
Product ID: 63304-962_cf0b0c2b-20a7-4142-8648-27bc3894cf73
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: bromocriptine mesylate
Dosage form: TABLET
Route: ORAL
Labeler: Sun Pharmaceutical Industries, Inc.
Application: NDA017962
Marketing category: NDA
Marketing start: 2016-12-22
Marketing end: 0000-00-00
Substance: BROMOCRIPTINE MESYLATE
Active strength: 3 mg/1
Pharmacologic classes: Ergot Derivative [EPC],Ergolines [CS]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	63304-962	63304-962-30	I	Inactivated by FDA		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	`bd6a592717d7…`	`303034d00443…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N017962-001	PARLODEL	BROMOCRIPTINE MESYLATE	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982
N017962-002	PARLODEL	BROMOCRIPTINE MESYLATE	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
N017962-001	AB
N017962-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N017962-002	PARLODEL	EQ 5MG BASE	CAPSULE / ORAL	AB	RLD	1982-03-01	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N017962-002	PARLODEL	EQ 5MG BASE	CAPSULE / ORAL	AB	RLD	1982-03-01	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N017962-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N017962-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N017962-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N017962-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N017962-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N017962-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N017962-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N017962-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N017962-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N017962-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N017962-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N017962-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N017962-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N017962-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N017962-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N017962-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N017962-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N017962-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N017962-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N017962-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N017962-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N017962-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N017962-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N017962-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N017962-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N017962-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N017962-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N017962-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N017962-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N017962-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N017962-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N017962-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N017962-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N017962-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N017962-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N017962-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N017962-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N017962-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N017962-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N017962-002	AB	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
6c13b22c-b3ba-4127-b768-0132dd5ab0d1	Product name	1	20230829
90f4f2b3-d032-9eaf-93c5-f165b5a4c90e	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63304-962-01	2022-01-28	C162847	48780-1	d6a99b39-a070-a426-e053-dadaa90af4c2	Bromocriptine Mesylate Tablets, USP Bromocriptine Mesylate Capsules, USP Rx Only
63304-962-30	2022-01-28	C162847	48780-1	d6a99b39-a070-a426-e053-dadaa90af4c2	Bromocriptine Mesylate Tablets, USP Bromocriptine Mesylate Capsules, USP Rx Only

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
63304-962-01	BROMOCRIPTINE MESYLATE	100 in 1 BOTTLE	TABLET	100		4
63304-962-30	BROMOCRIPTINE MESYLATE	30 in 1 BOTTLE	TABLET	30		4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63304-962-01	EA - Each	63304-962	cdf797ac-8b79-4c1d-844b-005d7f09dbec	1	2017-03-06
63304-962-30	EA - Each	63304-962	137ae8c4-d720-4bbe-85f8-15296741ada0	1	2017-03-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63304-962	BROMOCRIPTINE MESYLATE TABLET BROMOCRIPTINE MESYLATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES, INC.]	4	Legacy NDC, 2 package rows	20200212_44cc1e5f-c509-40e6-ac51-eba6d0440b16.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Bromocriptine Mesylate	BROMOCRIPTINE MESYLATE	ANI Pharmaceuticals, Inc.	17f3a343-1782-4799-95ba-31dfe93be2cf	2026-07-27	Warnings, Adverse reactions	Exact identifier application applno (NDA): 017962 application number: NDA017962
Bromocriptine Mesylate	BROMOCRIPTINE MESYLATE	American Health Packaging	ddd292a5-72af-448f-8b88-cc4fd99ec783	2026-06-12	Warnings, Adverse reactions	Exact identifier application applno (NDA): 017962 application number: NDA017962

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
FFP983J3OD	BROMOCRIPTINE MESYLATE	22260-51-1	BROMOCRIPTINE MESYLATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197411	bromocriptine mesylate 2.5 MG Oral Tablet	PSN	44cc1e5f-c509-40e6-ac51-eba6d0440b16	4
197412	bromocriptine mesylate 5 MG Oral Capsule	PSN	44cc1e5f-c509-40e6-ac51-eba6d0440b16	4
197411	bromocriptine 2.5 MG Oral Tablet	SCD	44cc1e5f-c509-40e6-ac51-eba6d0440b16	4
197412	bromocriptine 5 MG Oral Capsule	SCD	44cc1e5f-c509-40e6-ac51-eba6d0440b16	4
197411	bromocriptine (as bromocriptine mesylate) 2.5 MG Oral Tablet	SY	44cc1e5f-c509-40e6-ac51-eba6d0440b16	4
197412	bromocriptine 5 MG (as bromocriptine mesylate 5.74 MG) Oral Capsule	SY	44cc1e5f-c509-40e6-ac51-eba6d0440b16	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63304-962-30	63304096230	30 TABLET in 1 BOTTLE (63304-962-30)	30 tablet	2016-12-22	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Bromocriptine Mesylate Tablets, USP Bromocriptine Mesylate Capsules, USP Rx Only	Sun Pharmaceutical Industries, Inc. \| Halo Pharmaceutical Inc	2020-02-06	HUMAN PRESCRIPTION DRUG LABEL	4